ADENOASSOCIATED VIRUS TYPE 2-MEDIATED TRANSDUCTION OF MURINE HEMATOPOIETIC-CELLS WITH LONG-TERM REPOPULATING ABILITY AND SUSTAINED EXPRESSION OF A HUMAN GLOBIN GENE IN-VIVO
S. Ponnazhagan et al., ADENOASSOCIATED VIRUS TYPE 2-MEDIATED TRANSDUCTION OF MURINE HEMATOPOIETIC-CELLS WITH LONG-TERM REPOPULATING ABILITY AND SUSTAINED EXPRESSION OF A HUMAN GLOBIN GENE IN-VIVO, Journal of virology, 71(4), 1997, pp. 3098-3104
Adeno-associated virus type 2 (AAV), a nonpathogenic human parvovirus,
is gaining attention as a vector for potential use in human gene ther
apy. We and others have described AAV-mediated beta-globin gene transf
er and expression in established human and murine erythroleukemia cell
lines in vitro. However, successful AAV-mediated globin gene transduc
tion of hematopoietic stem cells and long-term expression in vivo in p
rogeny cells have not been documented. We report here that infection o
f murine hematopoietic bone marrow cells ex vivo with a recombinant AA
V vector containing the genomic copy of a normal human globin gene fol
lowed by transplantation of these cells into lethally irradiated conge
nic mice resulted in efficient gene transfer into hematopoietic cells
with long-term repopulating ability as detected by the presence of the
human globin gene sequences in bone marrow and spleen in primary reci
pient mice for at least 6 months. Long-term expression of the human gl
obin gene was also detected in bone marrow, but not in spleen, in prim
ary recipient mice, Furthermore, in secondary-transplant experiments,
we were also able to document the presence as well as expression of th
e transduced human globin gene in mouse bone marrow for up to 3 months
, These results provide further support for potential use of the AAV-b
ased vector system in gene therapy of human hemoglobinopathies in gene
ral and sickle-cell anemia and beta-thalassemia in particular.